Glenview Trust CO Edwards Lifesciences Corp Transaction History

Glenview Trust CO

$5.27 Billion
Q4 2024

A detailed history of Glenview Trust CO transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Glenview Trust CO holds 357,562 shares of EW stock, worth $27.1 Million. This represents 0.5% of its overall portfolio holdings.

Number of Shares

357,562

Previous 415,544 13.95%

Holding current value

$27.1 Million

Previous $27.4 Million 3.47%

% of portfolio

0.5%

Previous 0.53%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 10, 2025	SELL	$64.54 - $75.92 $3.74 Million - $4.4 Million	-57,982 Reduced 13.95%	357,562 $26.5 Million
Q3 2024 Nov 12, 2024	SELL	$59.7 - $93.78 $669,535 - $1.05 Million	-11,215 Reduced 2.63%	415,544 $27.4 Million
Q2 2024 Aug 14, 2024	BUY	$84.3 - $94.31 $1.67 Million - $1.86 Million	19,770 Added 4.86%	426,759 $39.4 Million
Q1 2024 May 14, 2024	BUY	$72.54 - $95.56 $1.47 Million - $1.94 Million	20,266 Added 5.24%	406,989 $38.9 Million
Q4 2023 Feb 12, 2024	SELL	$61.71 - $77.76 $244,309 - $307,851	-3,959 Reduced 1.01%	386,723 $29.5 Million
Q3 2023 Nov 13, 2023	BUY	$69.28 - $93.38 $2.04 Million - $2.75 Million	29,436 Added 8.15%	390,682 $27.1 Million
Q2 2023 Aug 14, 2023	BUY	$81.41 - $94.33 $1.58 Million - $1.83 Million	19,424 Added 5.68%	361,246 $34.1 Million
Q1 2023 May 09, 2023	BUY	$74.26 - $84.51 $1.63 Million - $1.86 Million	22,017 Added 6.88%	341,822 $28.3 Million
Q4 2022 Feb 08, 2023	BUY	$68.3 - $87.44 $10.1 Million - $13 Million	148,341 Added 86.51%	319,805 $23.9 Million
Q3 2022 Nov 04, 2022	SELL	$82.37 - $107.29 $485,983 - $633,011	-5,900 Reduced 3.33%	171,464 $14.2 Million
Q2 2022 Aug 10, 2022	SELL	$86.5 - $128.27 $1.4 Million - $2.08 Million	-16,233 Reduced 8.38%	177,364 $16.9 Million
Q1 2022 May 11, 2022	SELL	$101.96 - $128.34 $3.38 Million - $4.26 Million	-33,156 Reduced 14.62%	193,597 $22.8 Million
Q4 2021 Feb 10, 2022	SELL	$106.37 - $130.68 $3.8 Million - $4.67 Million	-35,749 Reduced 13.62%	226,753 $29.4 Million
Q3 2021 Nov 12, 2021	SELL	$102.91 - $122.75 $1.38 Million - $1.65 Million	-13,430 Reduced 4.87%	262,502 $29.7 Million
Q2 2021 Aug 11, 2021	BUY	$83.84 - $104.76 $1.03 Million - $1.28 Million	12,243 Added 4.64%	275,932 $28.6 Million
Q1 2021 May 12, 2021	BUY	$78.68 - $90.67 $207,321 - $238,915	2,635 Added 1.01%	263,689 $22.1 Million
Q4 2020 Feb 02, 2021	BUY	$71.69 - $91.23 $8,387 - $10,673	117 Added 0.04%	261,054 $23.8 Million
Q3 2020 Nov 12, 2020	SELL	$67.19 - $87.44 $64,972 - $84,554	-967 Reduced 0.37%	260,937 $20.8 Million
Q2 2020 Aug 12, 2020	BUY	$57.54 - $76.95 $10.3 Million - $13.8 Million	179,307 Added 217.09%	261,904 $18.1 Million
Q1 2020 Apr 28, 2020	BUY	$52.41 - $81.0 $152,146 - $235,143	2,903 Added 3.64%	82,597 $15.6 Million
Q4 2019 Feb 06, 2020	SELL	$71.7 - $82.09 $70,409 - $80,612	-982 Reduced 1.22%	79,694 $18.6 Million
Q3 2019 Nov 14, 2019	SELL	$61.55 - $75.43 $115,898 - $142,034	-1,883 Reduced 2.28%	80,676 $17.7 Million
Q2 2019 Aug 08, 2019	BUY	$55.74 - $64.41 $113,709 - $131,396	2,040 Added 2.53%	82,559 $0
Q1 2019 May 14, 2019	BUY	$47.89 - $64.05 $65,274 - $87,300	1,363 Added 1.72%	80,519 $15.4 Million
Q4 2018 Feb 14, 2019	BUY	$46.41 - $56.94 $92,680 - $113,709	1,997 Added 2.59%	79,156 $12.1 Million
Q3 2018 Nov 14, 2018	BUY	$45.7 - $58.03 $3.53 Million - $4.48 Million	77,159 New	77,159 $13.4 Million
Q2 2018 Aug 10, 2018	SELL	$42.45 - $51.3 $3.18 Million - $3.85 Million	-75,027 Closed	0 $0
Q1 2018 May 14, 2018	BUY	$37.19 - $47.45 $188,664 - $240,713	5,073 Added 7.25%	75,027 $0
Q4 2017 Feb 06, 2018	BUY	$33.79 - $39.39 $386,658 - $450,739	11,443 Added 19.56%	69,954 $7.89 Million
Q3 2017 Nov 07, 2017	BUY	$36.29 - $38.83 $2.12 Million - $2.27 Million	58,511	58,511 $6.4 Million

Others Institutions Holding EW

# of Institutions

1,378

Shares Held

485M

Call Options Held

6.77M

Put Options Held

3.25M

View Full List

About Edwards Lifesciences Corp

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $46.8B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

More about EW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Glenview Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Glenview Trust CO with notifications on news.

Account

Glenview Trust CO Edwards Lifesciences Corp Transaction History